Primary record
13-Ethylgon-4-ene-3,17-dione; Levonorgestrel Imp. L (Pharmeuropa); Levodione; 18-Methyl-19-norandrost-4-ene-3,17-dione; Levonorgestrel Imp. L (EP); Norgestrel Related Compound L; Levonorgestrel Impurity L
- 库存
- 1,277 克
- 纯度
- 99.7 %
- CAS
- 21800-83-9
化合物标识与属性
- CAS
- 21800-83-9
- PubChem CID
- 10379264
- SMILES
- CC[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=CC(=O)CC[C@H]34
- Canonical SMILES
- CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CCC2=O
名称与同义词
- D-Ethylgonendione
- Ethylgonendione
- D-Ethyl gonendione
- DL-Ethylgonendione
- Levodione
- DL-Ethylgonedione
- 21800-83-9
- 13-Egedo
- Levonorgestrel EP Impurity L
- Gon-4-ene-3,17-dione, 13-ethyl-
- 13-ethylgon-4-ene-3,17-dione
- RefChem:390535
- IH07J8F03F
- 13-Ethyl-gon-4-ene-3,17-dione
- UNII-IH07J8F03F
- MFCD08457890
- 18-Methylestr-4-ene-3,17-dione
- 13beta-ethylgon-4-en-3,17-dione
- SBLHOJQRZNGHLQ-ATIFRJIPSA-N
- DTXSID801020560
- SCHEMBL1422567
- (+)-13-Ethylgon-4-ene-3,17-dione
- LEVODIONE [EP IMPURITY]
- 18-Methyl-estr-4-ene-3,17-dione
- 23477-67-0
- 5-hydroxypyrimidine-2-carbonitrile
- DTXCID201478343
- 18-methyl-4-estren-3,17-dione
- 13-ethyl-gon-4-en-3,17-dione
- 18-Methylestr-4-en-3,17-dione
- C19H26O2
- 13I2-Ethylgon-4-en-3,17-dione
- 13beta-ethyl-gon-4-en-3,17-dione
- 13beta-Ethylgon-4-ene-3,17-dione
- 13beta-Ethylgona-4-ene-3,17-dione
- 18-Methyl-19-norandrost-4-ene-3,17-dione
- AKOS017343453
- ZINC238809414
- ACN-037313
- FE23047
- CID10379264
- (8R,9S,10R,13S,14S)-13-ethyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-dione
- SC-15763
- SY053177
- (+)-13-b-Ethylgon-4-ene-3,17-dione
- 13-Ethyl-19-nor-4-androsten-3,17-dion
- J678.794K
- 18a-Homo-19-norandrost-4-ene-3,17-dione
- E0921
- FT-0668283
- FT-0772233
- LEVONORGESTREL IMPURITY [EP IMPURITY]
- Gon-4-ene-3,17-dione, 13-ethyl-, (+/-)-
- EC 606-833-1
- M-1344
- NORGESTREL RELATED COMPOUND L [USP-RS]
- T72090
- 800E839
- (+)-13.BETA.-ETHYLGON-4-ENE-3,17-DIONE
- (8R,9S,10R,13S,14S)-13-Ethyl-7,8,9,10,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17(2H,6H)-dione
- Levonorgestrel Impurity L (18-Methylester-4-ene-3,17-dione)
- 13-Ethylgon-4-ene-3,17-dione (Levodione; 18-Methyl-19-norandrost-4-ene-3,17-dione)
- (3aS,3bR,9aR,9bS,11aS)-11a-ethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthrene-1,7-dione
- (3aS,3bR,9aR,9bS,11aS)-11a-Ethyl-2,3,3a,4,5,8,9,9a,9b,10,11,11a-dodecahydro-1H-cyclopenta[a]phenanthrene-1,7(3bH)-dione
- (3AS,3BR,9AR,9BS,11AS)-11A-ETHYL-2H,3H,3AH,3BH,4H,5H,8H,9H,9AH,9BH,10H,11H-CYCLOPENTA[A]PHENANTHRENE-1,7-DIONE
- 13-Ethylgon-4-ene-3,17-dione; Levonorgestrel Imp. L (Pharmeuropa); Levodione; 18-Methyl-19-norandrost-4-ene-3,17-dione; Levonorgestrel Imp. L (EP); Norgestrel Related Compound L; Levonorgestrel Impurity L
- 606-833-1
- Levodione; D-Ethyl Gonendione; 13-Ethylgon-4-ene-3,17-dione; (+)-13-?-Ethylgon-4-ene-3,17-dione; 18-Methyl-19-norandrost-4-ene-3,17-dione; 18-Methylestr-4-ene-3,17-dione